Cureus
Cure8 research brief
Why This Matters
This review found that children with atopic dermatitis have a modestly higher risk of later developing IBD (both Crohn’s disease and ulcerative colitis). Awareness of this association may help clinicians and families consider GI symptoms promptly in children with AD.
Who Should Pay Attention
Pediatric patients with atopic dermatitis, parents and caregivers, pediatricians and dermatologists, gastroenterologists, and researchers studying pediatric immune-mediated comorbidities.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
Children with atopic dermatitis (AD) were found to have a higher risk of later developing inflammatory bowel disease (IBD) in this systematic review and meta-analysis of cohort and case–control studies.
The pooled odds ratio for IBD in children with AD versus controls was 1.44 (95% CI 1.26–1.64); subgroup analyses showed increased risks for both Crohn’s disease (OR 1.46) and ulcerative colitis (OR 1.27). The authors report substantial heterogeneity across the included studies and note that the evidence base comprised four studies.
These results suggest clinicians and caregivers should be aware of a possible association between pediatric AD and later IBD, but this study does not establish causation or change clinical management by itself. The review highlights the need for further prospective pediatric research to clarify mechanisms, timing, and potential shared risk factors.
If you are a parent or clinician noticing persistent gastrointestinal symptoms in a child with AD, discuss those symptoms with your healthcare provider for appropriate evaluation; this review does not provide guidance on screening or treatment.
This brief summarizes the article abstract and pooled-analysis results reported by the authors; Cureus’ abstract was the source for this summary.
Keep In Mind
The analysis pooled only four studies and showed substantial heterogeneity (I² = 70%), so results should be interpreted cautiously. This is an abstract-based summary of the Cureus article; it does not replace reading the full paper or clinical guidance. Association does not prove causation.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationCureus
AuthorsAgostina Loiacono, Amulya Adusumilli, Kaushikkumar S Barot +5 more
Study typeReview
Indexed viaOpenAlex
Source typeResearch paper
PublishedJul 15, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Real-world patterns of inflammatory bowel disease treatment across adult and pediatric populations: a nationwide cohort study in South Korea
Patients, families, and clinicians may care because the study shows pediatric-onset IBD is more often Crohn's and that children begin advanced therapies earlier than adults. The adult persistence data for vedolizumab and...
Quantitative Analysis of Retinal and Choroidal Microvascular Changes in Adult IBD Patients: Insights into the Gut-Retina Axis.
The study suggests measurable retinal and choroidal microvascular differences in people with IBD versus controls, which could point to systemic vascular effects of inflammation and offer noninvasive biomarker...
Symptoms of ‘invisible disease’ that half a million Brits suffer as cases linked to scaly skin condition
The study suggests a possible link between psoriasis, leaky gut, and Crohn’s disease—topics that could help explain why some people with psoriasis report more gut problems. People with psoriasis or IBD may find the...